New Generation of Vaccine Adjuvants: Worst Ever?

by Heidi Stevenson

A new generation of vaccine adjuvants is being rolled out, literally mass produced. They’re touted as safe, but they share a dirty secret: They’re oil-based, which could make them the most dangerous yet in a product line that is, by definition, toxic.

All vaccine adjuvants are, by definition, toxic. Their function is to stimulate the immune system, that is, to initiate a response to a toxic agent. So, a new generation of adjuvants is being promoted as less toxic than any that have come before, while at the same time doing an even better job of priming the immune system so it will react to weak antigens. This leads to the question of how an adjuvant can be both safer than previous adjuvants and also more capable of agitating the stronger immune system response required to promote antibody creation to weaker antigens.

These new adjuvants are made from outer membrane vesicles (OMVs). A vesicle is a cavity, or sac. In a bacterium, OMVs are sacs that protrude from the exterior—membrane—of its body to protect itself in hostile environments. An OMV’s function is to be toxic.

Recombinant DNA technology is used to engineer bacteria so that they make OMVs to be used as antigens or adjuvants, which are then processed and added to vaccines. All of these products that are grown on the surfaces of microbes have one thing in common: they are proteoliposomes:

A proteoliposome is a liposome with one or more proteins inserted.
A liposome is a minute spherical sac of phospholipid molecules enclosing a water droplet.
A phospholipid is a type of lipid.
A lipid is a fatty acid. That is, a lipid is a fat.

And that makes these new adjuvants, or antigens with adjuvants built in, particularly worrisome. Fats and oils are known to be exceptionally dangerous when injected. Their similarity to normal body tissues is the reason. Fats do not normally enter the body through injections. They are either digested or created by the body, in which case there’s no problem. However, injection is not a normal means for lipids to enter the body.

Therefore, an injected lipid can be seen by the immune system as an invader. Of course, the response to an invader is to create antibodies against it. Since lipids normally exist throughout the body, when the immune system is radicalized into seeing a lipid as the enemy, it’s attacked—wherever it’s found, even when it’s a normal part of the body.

That’s the definition of an autoimmune disorder: the body’s own immune system starts attacking itself.

It’s not a secret that injection of lipids causes autoimmune disorders. In fact, it’s so well known that lipid injection is a standard technique for creating autoimmune disorders in laboratory animals for study. In particular, the active ingredient in Freund’s adjuvant, a lipid, is used to create an analog of human rheumatoid arthritis in lab rats.

Yet, lipids, in the form of recombinantly-created OMVs, are being added to vaccines for injection into humans!

Why Move to OMV Adjuvants?

The push for OMV adjuvants is happening because vaccine antigens—the part of a vaccine that’s supposed to trigger an autoimmune response that results in antibodies—need to create a strong immune response. But that’s not an easy task unless the antigen is a live microbe, which could cause a full-fledged disease. That’s why weakened or killed microbes have traditionally been used.

However, such weakened and killed microbes are not easy to produce, nor can the process be hurried. It is, therefore, expensive and, in the case of influenza, can take too long to respond to an ongoing outbreak. So, the modern approach is to utilize bits of microbes, or better yet, to grow those bits through recombinant DNA, such as in tobacco plants. The problem with this method is that these protein bits don’t create much of an immune response. Therefore, since the old standard, aluminum, doesn’t accomplish the job well enough, stronger adjuvants are required to initiate that response.

That’s why there’s a rush to implement OMV antigens and adjuvants. Once the process for a particular antigen or adjuvant is worked out, it becomes a relatively inexpensive process to grow it on a large scale for vaccines.

At this point, there is one vaccine with an OMV adjuvant on the market, Cervarix. Its adjuvant is marketed as AS04. It contains aluminum and OMV-derived 3-O-desacyl-4’-monophosphoryl lipid A (MPL). You can see from the chemical name that MPL is a lipid.

OMV Adjuvant Safety?

Adjuvants were discovered by accident when it was noted that dirty—literally dirty, contaminated—vaccine containers produced better results in terms of a vaccine’s ability to create antibodies. It was literally the dirty secret of vaccinology, and led to the intentional contamination of vaccines. The contaminants were relabeled as adjuvants.

Of course, there are side effects to adjuvants. The one that became standard, aluminum, is a known toxin. But, as long as it made the vaccine more effective at producing antibodies, the toxic properties of aluminum were—and still are—swept under the rug.

Other adjuvants had been tried, but all were even more toxic. Among the very worst were ones based on oils, Freund’s adjuvants. These were quickly determined to be far too toxic for use in vaccines, though they did find another marketable use. Freund’s adjuvants are now routinely used in medical research because they create the equivalent of human autoimmune disorders, such as rheumatoid arthritis, in laboratory animals, which are then studied to find treatments for the human disorders.

Now they have found OMV adjuvants, which are being promoted as the safest yet. A recent report in Proceedings of the National Academy of Sciences (PNAS), discusses “a less toxic mixture of monophosphorylated lipid A species (MPL)” made through the OMV methodology. Notice that the emphasis is on “less toxic”.

The fallacious claim that OMV lipids are safe is based on their being natural. It’s that very fact, that they’re natural—literally analogs of normal body chemistry—that makes them so dangerous. Their injection can cause them to be seen as toxins—which, of course, in this context they are—which can result in antibodies being developed against chemicals that are naturally found in the body. An autoimmune disease is the body’s immune system turning on itself.

There is, though, a great deal of emphasis on OMV lipids’ ability to elicit a strong immune system response to create antibodies. Just how something can be less toxic, yet cause a stronger response to toxicity is not explored.

Apparently, it’s to be taken on faith that these lipids are safe, when all other lipids are too dangerous for use in humans. But where are the trials to prove it?

Slipping Around the Approval Process

The FDA has made clear that they don’t approve adjuvants. Their logic is that adjuvants are not produced for end users. They’re produced for use in products that go to end users. The FDA doesn’t focus on individual ingredients in medical products. So they approve vaccines that include adjuvants, thus evading the issue of adjuvants’ toxicity.

Obviously, you cannot run tests of products that are intended to do harm, which is the case with all vaccine adjuvants, and hope to demonstrate safety. So, you won’t see safety trials of them. It would, of course, be considered unethical.

But apparently not so unethical that there’s any reason to stop their use in vaccines.

OMV adjuvants are now being promoted as “designer bacteria”. They’re being touted as safe, yet better able to elicit a response from weak antigens—a process that, by definition, requires more toxic adjuvants, not less toxic ones.

So, are the new generation of OMV adjuvants the worst ever? Is there any reason to assume otherwise?

Of one thing we can be certain: We’ll find out on the bodies of our children. These adjuvants are now being rolled out in a big way. They’re the basis of the enormous number of vaccines in the pipeline.

Sources:

  1. Modulating the innate immune response by combinatorial engineering of endotoxinPNAS, Brittany D. Needham, Sean M. Carroll, David K. Giles, George Georgiou, Marvin Whiteley, andM. Stephen Trent
  2. Bacterial outer membrane vesicles and the host–pathogen interactionGenes and Development, Meta J. Kuehn and Nicole C. Kesty
  3. Outer Membrane Vesicles Derived from Escherichia coli Induce Systemic Inflammatory Response Syndrome, PLoS One, Kyong-Su Park, Kyoung-Ho Choi, You-Sun Kim, Bok Sil Hong, Oh Youn Kim, Ji Hyun Kim, Chang Min Yoon, Gou-Young Koh, Yoon-Keun Kim, Yong Song Gho, doi:10.1371/journal.pone.0011334
  4. Outer membrane vesicle of Neisseria meningitidis serogroup B as an adjuvant in immunization of rabbit against Neisseria meningitidis serogroup AAfrican Journal of Microbiology Research, Seyed Davar Siadat, Saied Reza Naddaf, Mehrangiz Zangeneh, Arfa Moshiri, Seyed Mehdi Sadat, Mehdi Shafiee Ardestani, Mohammad Hassan Pouriayevali, Safieh Amini, and Mohammad Reza Aghasadeghi. DOI: 10.5897/AJMR11.361
  5. Briefing Materials for the Meeting of the Vaccines and Related Biological Products Advisory Committee, 7th April, 2011
  6. Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization SchedulesA Randomized Controlled Trial, doi:10.1001/jama.2012.85
  7. Delivery of foreign antigens by engineered outer membrane vesicle vaccinesPNAS, David J. Chen, Nikolaus Osterrieder, Stephan M. Metzger, Elizabeth Buckles, Anne M. Doody, Matthew P. DeLisa, and David Putnam
  8. Outer membrane vesicle of Neisseria meningitidisserogroup B as an adjuvant to induce specific antibody response against the lipopolysaccharide of Brucella abortus S99
  9. Contribution of bacterial outer membrane vesicles to innate bacterial defense, doi:10.1186/1471-2180-11-258
  10. Analysis of outer membrane vesicle associated proteins isolated from the plant pathogenic bacterium Xanthomonas campestris pv. campestris, doi:10.1186/1471-2180-8-87
  11. PorA Variable Regions of Neisseria meningitidisEmerging Infectious Diseases
  12. Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes
  13. Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response. Infection and Immunity, doi:  10.1128/IAI.71.9.5210-5218.2003
  14. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled studyThe Lancet, doi:10.1016/S0140-6736(11)61713-3
  15. Use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in a clinical trial in 3630 infants
  16. Adjuvant Activity of Emulsan, a Secreted Lipopolysaccharide fromAcinetobacter calcoaceticus, doi:  10.1128/CDLI.9.6.1240-1247.2002
  17. Lipopolysaccharide Vaccine Adjuvant
  18. Contribution of bacterial outer membrane vesicles to innate bacterial defense, BioMed Central (open access), Andrew J Manning and Meta J Kuehn
  19. Analysis of outer membrane vesicle associated proteins isolated from the plant pathogenic bacterium Xanthomonas campestris pv. campestris, BioMed Central (open access), Vishaldeep K Sidhu, Frank-Jörg Vorhölter, Karsten Niehaus, and Steven A Watt
  20. Routine 4CMenB immunizations effective against meningococcal strains in infants
  21. Liposomal malaria vaccine in humans: A safe and potent adjuvant strategyPNAS, L F Fries, D M Gordon, R L Richards, J E Egan, M R Hollingdale, M Gross, C Silverman, and C R Alving

…bless you all…

What Is Antiphospholipid Antibody Syndrome?

Antiphospholipid (AN-te-fos-fo-LIP-id) antibody syndrome (APS) is an autoimmune disorder. Autoimmune disorders occur if the body’s immune system makes antibodies that attack and damage tissues or cells.

Antibodies are a type of protein. They usually help defend the body against infections. In APS, however, the body makes antibodies that mistakenly attack phospholipids—a type of fat.

Phospholipids are found in all living cells and cell membranes, including blood cells and the lining of blood vessels.

When antibodies attack phospholipids, cells are damaged. This damage causes blood clots to form in the body’s arteries and veins. (These are the vessels that carry blood to your heart and body.)

Usually, blood clotting is a normal bodily process. Blood clots help seal small cuts or breaks on blood vessel walls. This prevents you from losing too much blood. In APS, however, too much blood clotting can block blood flow and damage the body’s organs.

Overview

Some people have APS antibodies, but don’t ever have signs or symptoms of the disorder. Having APS antibodies doesn’t mean that you have APS. To be diagnosed with APS, you must have APS antibodies and a history of health problems related to the disorder.

APS can lead to many health problems, such as stroke, heart attack, kidney damage, deep vein thrombosis (throm-BO-sis), and pulmonary embolism (PULL-mun-ary EM-bo-lizm).

APS also can cause pregnancy-related problems, such as multiple miscarriages, a miscarriage late in pregnancy, or a premature birth due to eclampsia (ek-LAMP-se-ah). (Eclampsia, which follows preeclampsia, is a serious condition that causes seizures in pregnant women.)

Very rarely, some people who have APS develop many blood clots within weeks or months. This condition is called catastrophic antiphospholipid syndrome (CAPS).

People who have APS also are at higher risk for thrombocytopenia (THROM-bo-si-to-PE-ne-ah). This is a condition in which your blood has a lower than normal number of blood cell fragments called platelets (PLATE-lets). Antibodies destroy the platelets, or they’re used up during the clotting process. Mild to serious bleeding can occur with thrombocytopenia.

APS can be fatal. Death may occur as a result of large blood clots or blood clots in the heart, lungs, or brain.

Outlook

APS can affect people of any age. However, it’s more common in women and people who have other autoimmune or rheumatic (ru-MAT-ik) disorders, such as lupus. (“Rheumatic” refers to disorders that affect the joints, bones, or muscles.)

APS has no cure, but medicines can help prevent its complications. Medicines are used to stop blood clots from forming. They also are used to keep existing clots from getting larger. Treatment for APS is long term.

If you have APS and another autoimmune disorder, it’s important to control that condition as well. When the other condition is controlled, APS may cause fewer problems.

…bless you all…

HPV, Tetanus Vaccine Causes New Disease: New Vaccines Worse?

by Heidi Stevenson

The vaccine junta is not only unconcerned with vaccine-induced diseases, it’s massively gearing up this vaccine arms race against the human race. It’s known that tetanus vaccine causes a new disease, antiphospholipid syndrome. New adjuvants are composed of phospholipids, a potential disaster.

The tetanus vaccine causes a new disease known both as Hughes syndrome and antiphospholipid syndrome (APS). It’s an autoimmune condition that can attack any part of the body, though is best noted for heart attacks and killing fetuses. It’s likely that APS will become more common with the new generation of vaccine adjuvants now being produced.

The sufferers of (APS) are mostly women, and its diagnosis is often made as a result of multiple pregnancy losses. As is typical of new diseases, research is focused on finding a genetic cause, in spite of the fact that the connection with vaccines is well known and documented.

As the name implies, APS is a condition in which phospholipids, natural and necessary substances required by every part of the body, is seen as an infectious agent by the immune system. So, this substance that exists in every cell becomes subject to attack. Symptoms include:

  • Blindness
  • Cardiovascular:
    • Deep vein thrombosis (clots in veins)
    • Phlebitis
    • Thrombocytopenia (deficiency of blood platelets, causing bleeding & bruising)
    • Atherosclerosis
    • Pulmonary embolus (clots in the lungs)
    • Heart valve abnormatilies
    • Stroke
  • Headaches & migraines
  • Miscarriages
  • Neurological disorders:
    • Epilepsy
    • Chorea (sudden uncontrollable jittery movements)
    • Transverse myelitis (inflammation of the spinal cord)
    • Multiple sclerosis
    • Cognitive dysfunction
  • Skin disorders, including mottling, ulcers, and necrosis

APS can also be diagnosed—more accurately, misdiagnosed—as lupus erythematosus, which is another vaccine-induced condition.

APS and Vaccines

One study calls Hughes syndrome the “classical antiphospholipid syndrome”[1]. That study refers to similarities between plasma protein beta-2-glycoprotein-I (β2GPI), which is attacked in APS, and the tetanus vaccine. That is, the tetanus antigen has parts that are virtually identical to β2GPI, which is found virtually everywhere in the body.

Another study documents how APS can be induced in laboratory animals with tetanus vaccination[2]. Many large number of other studies document and investigate the connection between vaccines and antiphospholipid syndrome[3,4,5,6,7,8].

These studies leave little doubt that APS is caused by vaccines. That should come as little surprise, since it was first identified as a disease during the 1980s. If this disease existed prior to vaccines, it was so rare that it was unknown. Now, it can take its place among a growing list of vaccine-induced conditions, including rheumatoid arthritis, macrophagic myofasciitis, multiple sclerosis, autism, and siliconosis. The list keeps growing and many believe that all these conditions should be included under a single name, autoimmune/inflammatory syndrome induced by adjuvants, or ASIA.

Why New Generation Vaccines Are Especially Worrisome

Phospholipids are a primary part of your body, forming part of the membrane of every cell, among other functions. They’re under attack in APS. As can be seen with regard to tetanus vaccine, APS can be induced by the antigen when the epitope—the part of the antigen forming the pattern that autobodies are designed to attack—is similar to a particular part of the body.

What’s frightening is that phospholipids are becoming a primary ingredient of vaccines in the form of a new generation of adjuvants made via recombinant DNA by diddling with a part of pathogenic bacteria called outer membrane vesicles (OMVs).

OMVs allow for designer vaccine antigens and adjuvants. OMV adjuvants are, of course, being promoted as the safest ever developed. That safety claim is based on the fact that they’re so much like the body already. This is the same claim that’s been used to promote squalene, which, as we’ve recently seen with the tragic cases of narcolepsy in children after the squalene-laced flu vaccine, Pandemrix, was unleashed in Europe, can devastate lives. Gaia Health explained the issue in How the Flu Vaccine Causes Narcolepsy.

Squalene is a lipid. That’s what makes it so dangerous. OMVs are even more precisely analogous to human tissue, because they are not only lipids, they are phospholipids—which are precisely what the body attacks in APS. Therefore, we can anticipate that there will be ever-more cases of APS as we see the approval of ever-more OMV-based vaccines, which are in the pipeline now.

Have no doubt: these vaccines will be approved. The first one, Cervarix, is already out there—and it’s been deemed safe, in spite of evidence to the contrary.

People with APS are suffering from phospholipid antibodies that are erroneously destroying parts of the eye, cardiovascular system, brain, nerves, skin, reproductive system—in short, any part of the body. This self-destruction is induced by vaccine technologies. These technologies are presumed safe without adequate, if any, testing. Just how many people must suffer before this travesty is ended? When will the clearly mad purveyors of these technologies step back and question what they’re doing?

The fact is that there are not just one, but several generations of people who don’t even know what good health is. Worse, each successive generation is growing sicker than the previous one. And worst of all, the vaccine junta is not only unconcerned, it’s massively gearing up this vaccine arms race against the human race.

Sources:

  1. When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA)”Lupus, M Blank, E Israeli, Y Shoenfeld, doi: 10.1177/0961203312438115.
  2. Vaccine model of antiphospholipid syndrome induced by tetanus vaccineLupus, L Dimitrijević, I Živković, M  Stojanović, V Petrušić, S Živančević-Simonović, doi: 10.1177/0961203311429816.
  3. β2 glycoprotein 1 (β2GPI), the major target in anti phospholipid syndrome (APS), is a special human complement regulatorBlood, Katharina Gropp, Nadia Weber, Michael Reuter, Sven Micklisch, Isabell Kopka, Teresia Hallström and Christine Skerka, doi:10.1182/blood-2011-02-339564.
  4. Anti-β2 glycoprotein I (β2GPI) autoantibodies recognize an epitope on the first domain of β2GPIPNAS, G. Michael Iverson, Edward J. Victoria, and David M. Marquis.
  5. Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccineClinical and Experimental Immunology, J Martinuč Porobič, T Avčin, B Božič, M Kuhar, S Čučnik, M Zupančič, K Prosenc, T Kveder, and B Rozman, doi:  10.1111/j.1365-2249.2005.02923.x
  6. Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.
  7. ‘ASIA’ – autoimmune/inflammatory syndrome induced by adjuvants.
  8. Infections and vaccines in the etiology of antiphospholipid syndrome.
  9. Hughes Syndrome Foundation
  10. Antiphospholipid syndrome
  11. Learning About Antiphospholipid Syndrome (APS)
  12. The antiphospholipid syndrome (Hughes’ syndrome)
  13. APS Foundation of America

Vaccines cause autoimmune disorders!

…bless you all…

LESLIE CAROL BOTHA EXPOSES TRUTH ABOUT HPV VACCINES

Gardasil, Silgard and Cervarix may turn out to be the biggest medical hoax of the century should the information revealed on a recent KRFC radio broadcast be proven true. If indeed, the information presented during last Monday evening’s broadcast is accurate, HPV vaccines are nothing more than a worldwide exercise in profiteering.

Leslie Carol Botha regularly hosts a radio show based out of Fort Collins, Colorado called, “Holy Hormones, Honey — the Greatest Story Never Told.” She has been a health educator and broadcast journalist for 30 years.

On August 2, her guests were prominent cancer pathologist, Dr. Sin Hang Lee, and Norma Erickson, Vaccines Examiner for Examiner.com.

Ms. Botha has spent a great deal of time over the last few years investigating HPV vaccines and their effect on young women and children around the world. Even so, the information presented during this show shocked her beyond belief.

Leslie started her broadcast with a brief recap of facts that have already come to light during the ongoing HPV vaccine controversy. They are as follows:

  • Cervical cancer is not a major health issue for women under good gynecological care.
  • HPV vaccines may protect against four strains of high-risk HPV but the duration of effectiveness is not clear; best estimates to date are from 4 to 6 years
  • HPV vaccination does not eliminate the need for traditional cervical cancer screening
  • Prior exposure to vaccine-relevant strains of HPV can increase the risk of cancer by 44.6% if injected with Gardasil and 32.5% if injected with Cervarix
  • HPV is not transmitted solely via sexual contact, there are multiple other ways to have been exposed
  • There are already 278 reports to VAERS of abnormal pap smears post-vaccination

Following the recap, Norma Erickson explained the circumstances surrounding her original contact with Dr. Lee, including a couple of statements from his original 2007 petition to the FDA for reclassification of his HPV test kit that brought the value of HPV vaccinations into question. These statements were:

  • HPV does not cause cervical cancer, it is the persistant infection, not the virus, that determines the risk
  • 93% of women initially infected with a particular strain of HPV will not show the same strain four menstrual cycles later

Norma also stated that during one of her initial conversations with Dr. Lee, that he had disclosed the fact that the original studies to determine HPV type prevalence had been done with self-collected specimens by women in Costa Rica, a country with one of the highest cervical cancer rates in the world. These were the statistics used to market HPV vaccines to an American population where women have a 14 times greater chance of dying of digestive cancer than they do of cervical cancer.

Dr. Sin Hang Lee on women’s healthcare  (PR photo)

Enter, Dr. Sin Hang Lee, prominent cancer pathologist and HPV testing expert. Dr. Lee and his associates actually developed one of the most sensitive HPV test kit available. This test kit, which could be used in nearly any medical facility around the world can not only identify if HPV is present, it will accurately determine which of the 100+ strains of HPV are exhibited.

Because of a 20 year old error in FDA classification, this test cannot be currently marketed as the virology test it is. In order to market this test kit, the inventors must perform clinical trials, at a cost of hundreds of thousands of dollars, to prove it can accurately detect cancer — something it was not developed for, nor is it intended to do.

Following is a brief summary of the critical information Dr. Lee wants women the world over to know and understand:

  • Most cervical cancer deaths in the United States, and developed countries, are people who are not under regular OB/GYN care.
  • The National Cancer Institute has no data on which HPV genotypes are prevalent in the United States.
  • A CDC study showed that HPV types 16 and 18, the two HPV vaccine-relevant strains, are NOT the prevalent types in American women.
  • Three published papers on HPV prevalence in the U.S., indicated that types 62, 84 and 52 are the most prevalent. These are all classified as high-risk strains, none of which are targeted in either approved HPV vaccine.
  • If a person has prior exposure to vaccine-relevant HPV prior to injection, the vaccine provides no benefit, but does provide potential risks.
  • If a woman is infected with HPV-16 in January, HPV-18 in July, and HPV-31 in December, her cancer risk is zero. Even though these are all high risk types, they are considered transient. It takes repeated infection by the same type to perhaps pose a risk of cervical cancer.
  • Even when a woman has persistant infection by the same type, if her lifestyle is healthy (she does not smoke, does not take oral contraceptives, does not have multiple sexual partners, does not have a compromised immune system) her risk of cervical cancer is still minimal.
  • HPV is not necessarily a sexually transmittable virus–you can get it other ways.
  • American women currently spend $10 billion on unnecessary colposcopies (cervical biopsies) every year, primarily because the currently used HPV tests frequently display false positive results.
  • A study conducted by Harvard Medical School estimated that 95% of cervical biopsies in the United States are not necessary.
  • If a young woman is considering taking an HPV vaccine, it is critical that she know if she has been exposed to HPV, and if so, what genotype.
  • Nothing has been proven to be more effective at controlling cervical cancer than pap smear technology.

So why do HPV vaccine manufacturers, the CDC, and the National Cancer Institute tell physicians not to screen for HPV exposure prior to vaccination? Unfortunately for young women and children around the world, the answer appears to be abundantly clear.

…bless you all…

Sandy’s excellent poem

GARDASIL

 

Come here dear little children

Now you’re nine years old

We want the very best for you

So please be brave and bold

When you get this little jab

It’ll give you some pain

But it’ll be so good for you

Tho’ it might affect your brain

It gives your little bodies

Such a healthy feast:

Aluminium and histidine

Some virus strains and yeast

There’s polysorbate 80

But we don’t mind at all

The nurses here will catch you

If you do faint or fall

There’s borax which kills cockroaches

No joking, it is true

But the experts have told us

That it surely won’t kill you

There are many thousands

Of side effects we hear

But we hope that you’ll be lucky

And have nothing to fear

In fact nobody knows

If the jab will prevent

Any type of cancer

In any event

Some medical experts

Do in fact declare

That the jab may give you cancer

And they don’t know if it’s rare

We really want some grandchildren

When you become mature

The jab may make you sterile

Tho’ nobody is sure!

 

…bless you all…